We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current RDY market cap is 12.33B. The company's latest EPS is INR and P/E is N/A.
| Quarter End | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 63.6B | 68.49B | 69.32B | 72.18B | 74.53B |
| Operating Income | 16.47B | 16.93B | 18.88B | 19.58B | 18.8B |
| Net Income | 11.14B | 12.44B | 14.05B | 14.82B | 13.81B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 154.42B | 178.76B | 190.62B | 216.11B | 252.99B |
| Operating Income | 20.79B | 34.25B | 34.08B | 36.76B | 59.76B |
| Net Income | 19.5B | 20.26B | 19.52B | 21.83B | 45.07B |
| Quarter End | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 291.69B | 0 | 0 | 348.09B | 0 |
| Total Liabilities | 83.94B | 0 | 0 | 93.13B | 0 |
| Total Equity | 207.75B | 0 | 0 | 254.97B | 0 |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 224.66B | 232.25B | 266.17B | 297.47B | 322.85B |
| Total Liabilities | 84.42B | 76.27B | 89.75B | 105.35B | 89.99B |
| Total Equity | 140.24B | 155.99B | 176.42B | 192.12B | 232.86B |
| Quarter End | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | 15.94B | N/A | N/A | 29.18B | N/A |
| Investing | 810M | N/A | N/A | -12.75B | N/A |
| Financing | -23.15B | N/A | N/A | -8.51B | N/A |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | 28.7B | 29.84B | 35.7B | 28.11B | 58.88B |
| Investing | -7.73B | -4.92B | -22.66B | -26.39B | -41.37B |
| Financing | -21.33B | -25.16B | -298M | -2.42B | -26.86B |
| Market Cap | 12.33B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | 0.65% |
| Shares Outstanding | 166.53M |
| Average Volume (1 week) | 204.63k |
| Average Volume (1 Month) | 178.21k |
| 52 Week Change | 24.28% |
| 52 Week High | 77.72 |
| 52 Week Low | 53.12 |
| Spread (Intraday) | 8.93 (11.76%) |
| Company Name | Dr Reddys Laboratories Ltd |
| Address |
8-2-337, road no. 3, banjara hills hyderabad, andhra pradesh 500034 |
| Website | https://www.drreddys.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
